Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 9 | 2023 | 159 | 3.600 |
Why?
|
| Smoking Cessation | 6 | 2026 | 431 | 3.140 |
Why?
|
| HIV Infections | 11 | 2025 | 165 | 3.110 |
Why?
|
| Tobacco Use Cessation | 3 | 2026 | 36 | 2.410 |
Why?
|
| Papillomaviridae | 5 | 2018 | 90 | 1.990 |
Why?
|
| Vaginal Douching | 4 | 2018 | 4 | 1.940 |
Why?
|
| Sex Workers | 5 | 2018 | 5 | 1.870 |
Why?
|
| Sexual Partners | 6 | 2023 | 25 | 1.710 |
Why?
|
| Papillomavirus Vaccines | 2 | 2023 | 74 | 1.370 |
Why?
|
| Sex Work | 3 | 2016 | 3 | 1.330 |
Why?
|
| Condoms | 6 | 2016 | 17 | 1.240 |
Why?
|
| Sexual Behavior | 6 | 2015 | 91 | 1.240 |
Why?
|
| Telemedicine | 4 | 2026 | 228 | 1.230 |
Why?
|
| Adult | 27 | 2026 | 8125 | 1.170 |
Why?
|
| Vaccination | 3 | 2025 | 222 | 1.100 |
Why?
|
| Communication | 4 | 2020 | 185 | 1.050 |
Why?
|
| Female | 34 | 2026 | 15819 | 1.040 |
Why?
|
| Humans | 42 | 2026 | 29202 | 0.970 |
Why?
|
| Mouth Diseases | 2 | 2017 | 6 | 0.960 |
Why?
|
| Vietnam | 12 | 2025 | 46 | 0.930 |
Why?
|
| Motivational Interviewing | 1 | 2025 | 9 | 0.890 |
Why?
|
| Laos | 5 | 2026 | 20 | 0.870 |
Why?
|
| Oral Health | 2 | 2015 | 7 | 0.850 |
Why?
|
| Cancer Survivors | 1 | 2025 | 72 | 0.830 |
Why?
|
| Health Personnel | 2 | 2023 | 99 | 0.810 |
Why?
|
| Caregivers | 1 | 2025 | 122 | 0.810 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2023 | 105 | 0.770 |
Why?
|
| Male | 24 | 2026 | 14120 | 0.770 |
Why?
|
| Genotype | 5 | 2019 | 462 | 0.760 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 8 | 0.720 |
Why?
|
| Adolescent | 17 | 2025 | 3254 | 0.710 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2022 | 305 | 0.710 |
Why?
|
| Smoke-Free Policy | 1 | 2021 | 17 | 0.700 |
Why?
|
| Tobacco Products | 2 | 2026 | 209 | 0.680 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2021 | 63 | 0.670 |
Why?
|
| Students | 3 | 2012 | 203 | 0.670 |
Why?
|
| Middle Aged | 16 | 2025 | 7493 | 0.650 |
Why?
|
| Text Messaging | 1 | 2021 | 28 | 0.650 |
Why?
|
| Telephone | 1 | 2020 | 26 | 0.650 |
Why?
|
| Young Adult | 16 | 2025 | 2875 | 0.630 |
Why?
|
| Tobacco Smoking | 1 | 2020 | 38 | 0.620 |
Why?
|
| Cambodia | 5 | 2019 | 10 | 0.610 |
Why?
|
| Drug Users | 1 | 2019 | 11 | 0.610 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2026 | 414 | 0.600 |
Why?
|
| Smokers | 1 | 2020 | 129 | 0.590 |
Why?
|
| Pilot Projects | 5 | 2025 | 467 | 0.580 |
Why?
|
| Reproductive Tract Infections | 1 | 2018 | 1 | 0.570 |
Why?
|
| Cross-Sectional Studies | 11 | 2024 | 1012 | 0.560 |
Why?
|
| Self Report | 2 | 2015 | 124 | 0.520 |
Why?
|
| Tobacco | 3 | 2023 | 87 | 0.510 |
Why?
|
| United States | 9 | 2024 | 2269 | 0.500 |
Why?
|
| Motivation | 3 | 2016 | 217 | 0.490 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 349 | 0.490 |
Why?
|
| Self Efficacy | 3 | 2016 | 81 | 0.480 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2023 | 316 | 0.480 |
Why?
|
| Risk Factors | 10 | 2019 | 2144 | 0.470 |
Why?
|
| Judgment | 1 | 2015 | 31 | 0.450 |
Why?
|
| Oral Hygiene | 1 | 2015 | 3 | 0.450 |
Why?
|
| Rural Population | 3 | 2026 | 140 | 0.440 |
Why?
|
| Bisexuality | 1 | 2014 | 4 | 0.440 |
Why?
|
| Social Class | 2 | 2012 | 82 | 0.440 |
Why?
|
| Homosexuality, Male | 1 | 2014 | 17 | 0.430 |
Why?
|
| Prevalence | 6 | 2024 | 526 | 0.430 |
Why?
|
| Physicians | 1 | 2015 | 83 | 0.430 |
Why?
|
| Interpersonal Relations | 3 | 2016 | 65 | 0.430 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 155 | 0.420 |
Why?
|
| Social Perception | 2 | 2012 | 23 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 177 | 0.410 |
Why?
|
| Decision Making | 1 | 2015 | 179 | 0.410 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 1021 | 0.400 |
Why?
|
| Women's Health | 2 | 2012 | 61 | 0.400 |
Why?
|
| Mouth | 1 | 2013 | 37 | 0.390 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 610 | 0.390 |
Why?
|
| Nutrition Surveys | 4 | 2019 | 32 | 0.390 |
Why?
|
| Negotiating | 1 | 2013 | 11 | 0.380 |
Why?
|
| Sexism | 1 | 2012 | 9 | 0.380 |
Why?
|
| Reproductive Health | 1 | 2012 | 6 | 0.380 |
Why?
|
| Women | 1 | 2012 | 12 | 0.370 |
Why?
|
| Contraception Behavior | 1 | 2012 | 17 | 0.370 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 64 | 0.370 |
Why?
|
| Health Status Disparities | 1 | 2012 | 66 | 0.360 |
Why?
|
| Aged | 9 | 2025 | 5647 | 0.290 |
Why?
|
| Healthcare Disparities | 2 | 2024 | 99 | 0.280 |
Why?
|
| Interviews as Topic | 3 | 2018 | 164 | 0.260 |
Why?
|
| Risk-Taking | 2 | 2018 | 61 | 0.240 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2016 | 17 | 0.230 |
Why?
|
| Alcohol Drinking | 2 | 2024 | 181 | 0.230 |
Why?
|
| Health Behavior | 2 | 2020 | 159 | 0.230 |
Why?
|
| Commerce | 1 | 2026 | 61 | 0.230 |
Why?
|
| Urban Population | 1 | 2026 | 97 | 0.220 |
Why?
|
| Smartphone | 1 | 2026 | 85 | 0.220 |
Why?
|
| Alcohol Deterrents | 1 | 2024 | 2 | 0.220 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2025 | 32 | 0.220 |
Why?
|
| Psychotherapy | 1 | 2024 | 16 | 0.220 |
Why?
|
| Health Surveys | 3 | 2024 | 88 | 0.210 |
Why?
|
| Mobile Applications | 1 | 2025 | 82 | 0.210 |
Why?
|
| DNA, Viral | 2 | 2015 | 63 | 0.210 |
Why?
|
| Logistic Models | 2 | 2017 | 415 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 105 | 0.200 |
Why?
|
| Educational Status | 2 | 2014 | 112 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 166 | 0.200 |
Why?
|
| Tobacco Use | 1 | 2024 | 103 | 0.200 |
Why?
|
| Leadership | 1 | 2023 | 58 | 0.190 |
Why?
|
| Cigarette Smoking | 1 | 2024 | 85 | 0.190 |
Why?
|
| Residence Characteristics | 1 | 2023 | 106 | 0.190 |
Why?
|
| Retrospective Studies | 4 | 2025 | 2659 | 0.180 |
Why?
|
| Computers | 1 | 2022 | 31 | 0.180 |
Why?
|
| Socioeconomic Factors | 3 | 2024 | 264 | 0.180 |
Why?
|
| Workplace | 1 | 2021 | 31 | 0.170 |
Why?
|
| Crowdsourcing | 1 | 2021 | 4 | 0.170 |
Why?
|
| Environmental Exposure | 1 | 2021 | 53 | 0.170 |
Why?
|
| Social Behavior | 2 | 2012 | 54 | 0.170 |
Why?
|
| Single-Blind Method | 1 | 2021 | 48 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 485 | 0.170 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 360 | 0.160 |
Why?
|
| Self Care | 2 | 2011 | 42 | 0.160 |
Why?
|
| Texas | 1 | 2020 | 140 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2020 | 98 | 0.150 |
Why?
|
| Patient Education as Topic | 2 | 2011 | 92 | 0.150 |
Why?
|
| Mental Health Services | 1 | 2019 | 20 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 121 | 0.150 |
Why?
|
| Quality of Life | 1 | 2023 | 523 | 0.150 |
Why?
|
| Placenta Growth Factor | 1 | 2018 | 6 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 9 | 0.140 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 21 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 17 | 0.140 |
Why?
|
| Mental Health | 1 | 2019 | 111 | 0.140 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2018 | 17 | 0.140 |
Why?
|
| Health Promotion | 2 | 2011 | 180 | 0.140 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 49 | 0.140 |
Why?
|
| Needle Sharing | 1 | 2018 | 1 | 0.140 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 139 | 0.140 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2018 | 14 | 0.140 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2017 | 20 | 0.130 |
Why?
|
| Spleen | 1 | 2017 | 114 | 0.130 |
Why?
|
| Prognosis | 2 | 2025 | 817 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2019 | 235 | 0.130 |
Why?
|
| Neoplasms | 1 | 2025 | 887 | 0.120 |
Why?
|
| Disclosure | 1 | 2016 | 19 | 0.120 |
Why?
|
| Pest Control, Biological | 1 | 2015 | 1 | 0.120 |
Why?
|
| Wolbachia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Dengue | 1 | 2015 | 5 | 0.120 |
Why?
|
| Aedes | 1 | 2015 | 5 | 0.120 |
Why?
|
| Insect Vectors | 1 | 2015 | 12 | 0.120 |
Why?
|
| Tanzania | 1 | 2014 | 6 | 0.110 |
Why?
|
| Coinfection | 1 | 2015 | 20 | 0.110 |
Why?
|
| Biomarkers | 1 | 2018 | 789 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2016 | 209 | 0.110 |
Why?
|
| Stroke | 1 | 2017 | 261 | 0.100 |
Why?
|
| HIV Seropositivity | 2 | 2011 | 11 | 0.100 |
Why?
|
| Marijuana Use | 2 | 2024 | 44 | 0.100 |
Why?
|
| Alcoholism | 2 | 2024 | 122 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 270 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 145 | 0.090 |
Why?
|
| Focus Groups | 1 | 2012 | 105 | 0.090 |
Why?
|
| Universities | 1 | 2012 | 128 | 0.090 |
Why?
|
| Internet | 2 | 2011 | 129 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 16 | 0.090 |
Why?
|
| Sex Factors | 1 | 2012 | 473 | 0.080 |
Why?
|
| Smoking | 1 | 2015 | 480 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 1033 | 0.080 |
Why?
|
| Social Values | 1 | 2010 | 11 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 46 | 0.080 |
Why?
|
| Safe Sex | 1 | 2009 | 7 | 0.070 |
Why?
|
| Social Support | 1 | 2010 | 133 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 2070 | 0.060 |
Why?
|
| Schools | 1 | 2026 | 90 | 0.060 |
Why?
|
| Disulfiram | 1 | 2024 | 4 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2025 | 28 | 0.050 |
Why?
|
| Naltrexone | 1 | 2024 | 19 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2025 | 100 | 0.050 |
Why?
|
| Medicaid | 1 | 2024 | 55 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2025 | 75 | 0.050 |
Why?
|
| Medicare | 1 | 2024 | 126 | 0.050 |
Why?
|
| Marijuana Smoking | 1 | 2024 | 35 | 0.050 |
Why?
|
| Survival Rate | 1 | 2025 | 433 | 0.050 |
Why?
|
| Tobacco Use Disorder | 1 | 2024 | 117 | 0.050 |
Why?
|
| Infant | 1 | 2025 | 1066 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2025 | 1213 | 0.040 |
Why?
|
| Mutation | 1 | 2025 | 875 | 0.040 |
Why?
|
| Mass Screening | 1 | 2021 | 160 | 0.040 |
Why?
|
| Research Design | 1 | 2021 | 188 | 0.040 |
Why?
|
| Child | 1 | 2025 | 2354 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2018 | 18 | 0.040 |
Why?
|
| Leukocytes | 1 | 2017 | 72 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 261 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 95 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 794 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2017 | 88 | 0.030 |
Why?
|
| Neutrophils | 1 | 2017 | 185 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 741 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 903 | 0.030 |
Why?
|
| Pupa | 1 | 2015 | 2 | 0.030 |
Why?
|
| Australia | 1 | 2015 | 40 | 0.030 |
Why?
|
| African Americans | 1 | 2017 | 353 | 0.030 |
Why?
|
| Environment | 1 | 2015 | 66 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 1261 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1619 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 740 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2010 | 29 | 0.020 |
Why?
|
| Truth Disclosure | 1 | 2010 | 25 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 10802 | 0.010 |
Why?
|